TrialThe Journal of clinical psychiatry2009

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.

John W Newcomer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.